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A fase extratora de politiofeno (PTh), desenvolvida por eletropolimerização em haste de aço 
inox, foi avaliada para microextração em fase sólida (SPME) e análise por cromatografia líquida 
com detecção espectrofotométrica (LC-UV) de antidepressivos inibidores seletivos da recaptação 
de serotonina (citalopram, paroxetina, fluoxetina e sertralina) em amostras de plasma. A influência 
das variáveis da eletropolimerização (velocidade de varredura de potencial, potencial e ciclos de 
varredura) foi avaliada no desempenho SPME. As variáveis SPME (tempo de extração, temperatura, 
pH da matriz, força iônica e procedimento de dessorção), assim como a influência das proteínas 
do plasma no mecanismo de sorção, foram também avaliadas. O método SPME-PTh/LC-UV 
desenvolvido para a determinação de antidepressivos em amostras de plasma apresentou faixa 
linear de resposta do limite de quantificação (LOQ, 200-250 ng mL-1) a 4000 ng mL-1 e precisão 
interensaio com coeficiente de variação no intervalo de 11 a 15%. O método proposto poderá ser 
utilizado para a determinação de antidepressivos em amostras de plasma humano para análises 
toxicológicas de urgência, após a ingestão acidental ou suicida de doses altas de medicamentos.
Polythiophene (PTh) phase electropolymerized on the stainless steel wire was evaluated as solid-
phase microextraction (SPME), and analysis by liquid chromatography with spectrophotometric 
detection (LC-UV) for determination of new-generation antidepressants, selective serotonin 
reuptake inhibitors (SSRIs) (citalopram, paroxetine, fluoxetine and sertraline), in plasma samples. 
The influence of electropolymerization variables (scan rate, potential range and scan cycles) was 
evaluated on SPME performance. The SPME variables (extraction time, temperature, matrix pH, 
ionic strength and desorption procedure), as well as the influence of plasma proteins on sorption 
mechanisms were also evaluated. The SPME/LC-UV method developed for determination of 
antidepressants in plasma sample presented a linear range between the limit of quantification 
(LOQ, 200-250 ng mL-1) to 4000 ng mL-1, and interday precision with coefficient of variation 
(CV) ranged from 11 to 15%. The proposed method can be a useful tool for the determination of 
antidepressants in human plasma samples in urgent toxicological analysis after the accidental or 
suicidal intake of higher doses of medications.
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Introduction
Mood disorders represent a considerable portion of 
the diseases prevailing worldwide, with high suicide rates. 
The World Health Organization (WHO) estimates that 
depressive disorders will become the second most prevalent 
cause of illness-produced disability by 2020.1
Depressive disorders have been found to be significant 
risk factors for suicide. The use of drugs, like antidepressants 
(AD), for the treatment of mood disorders has a relatively 
short history and is still under rapid development. However, 
in the same way that antidepressants are used in the 
treatment of depressive disorders, they can also become 
the underlying cause of suicide. Although there has been 
significant decrease in suicide rates with the increased use 
of antidepressants, suicides have augmented due to the use 
of antidepressants. Therefore, toxicological surveillance of 
individuals who attempted suicide regarding the presence 
of AD medications is important for monitoring correlations 
between the use of AD and suicide rates in populations.2-7
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The development of highly efficient analytical 
instrumentation for the endpoint determination of drugs 
from biological samples involves sample pretreatment, 
which is usually necessary for the extraction, isolation and 
concentration of drugs encountered in complex matrices. 
This is because most analytical instruments cannot handle 
sample matrices directly.8
In the last decade, Arthur and Pawliszyn9 introduced 
the solid-phase microextraction (SPME) technique. This 
solventless technique combines analyte extraction and 
concentration in a single step, thereby reducing the required 
time for sample preparation. SPME has been successfully 
applied to the extraction of volatile and semi-volatile drugs 
from various sample matrices.8-10 However, the application 
of SPME to ionizable drug species is limited due to the 
neutral charge of commercial SPME coatings. This results 
in low coating/sample partition coefficient and poor analyte 
recovery. One promising alternative for the extraction 
of polar and ionic compounds is the use of conductive 
polymers as extraction phases.10,11
The conducting polymer coatings as polythiophene 
films12-16 presented multifunctional properties. Thus, their 
polymerization on metal wires by electrochemical or 
chemical methods has been described as a promising 
alternative for the development of new phases for the SPME 
technique, therefore expanding the potential application of 
this method.17
In the present work, polythiophene films were 
electropolymerized (cyclic voltammetry) on the surface 
of metal (stainless steel) wires, for the development of 
SPME phases. These polymeric films were evaluated 
as SPME phases for the liquid chromatography (LC) 
analysis of selective serotonin reuptake inhibitor (SSRI) 
antidepressants (Figure 1) in plasma samples for 
toxicological analysis purposes. The influence of plasma 
protein on the SPME process was also evaluated.
Experimental
Reagents and analytical standards
The fluoxetine and paroxetine analytical standards were 
donated by Eli Lilly Co. (Indianapolis, IN, USA) and Libbs 
Farmacêutica Ltda. (São Paulo-SP, Brazil), respectively. 
Citalopram and sertraline were acquired from F. Hoffmann-
La Roche Ltd. (Basel, Switzerland).
The diluted standard solutions of antidepressants 
were prepared considering the therapeutic range. For this 
purpose, their respective stock solutions (1 mg mL-1) were 
diluted in methanol. These solutions remained stable for 
45 days when they were stored at −20 °C. The water used 
to prepare the mobile phase was previously purified in a 
Milli-Q system (Millipore, Bedford, MA, USA).
Methanol, acetonitrile (both, HPLC grade), anhydrous 
dibasic sodium phosphate 99.4% and hydrochloric acid 
38% were purchased from J. T. Baker Chemical Co. 
(Phillipsburg, NJ, USA). Monobasic monohydrate sodium 
phosphate 99.6% and sodium borate 99.5% were acquired 
from Mallinckrodt Baker Inc. (Phillipsburg, NJ, USA). 
Sodium perchlorate (NaClO4) and tetrabutylammonium 
tetrafluoroborate (TBATFB) both 98% were provided by 
Acros Organics (Morris Plains, NJ, USA). The thiophene 
monomer 99% electrochemical grade was purchased from 
Sigma-Aldrich (St.Louis, MO, USA).
Plasma samples
The blank plasma (drug-free) with negative serology 
for hepatitis B and C, Chagas disease, HTLV I/II, TGP and 
syphilis was kindly supplied by Hospital das Clínicas de 
Ribeirão Preto (University of São Paulo, Ribeirão Preto-SP, 
Brazil).
The synthetic plasma sample was prepared by using 
sodium chloride (145 mmol L-1), potassium chloride 
(4.5 mmol L-1), calcium chloride (32.5 mmol L-1), magnesium 
chloride (0.8 mmol L-1), urea (2.5 mmol L-1) and d-glucose 
(4.7 mmol L-1).18 The pH of synthetic plasma solution was 
adjusted to 7.4 using sodium hydroxide solution (1 mol L-1). 
Chromatographic conditions
All the analyses were performed on a Varian ProStar 
230 liquid chromatograph (Palo Alto, CA, USA) with 
UV detector (λ = 230 nm). The drugs were separated in 
a LiChrospher60 RP-Select B (5 µm, 250 × 4 mm i.d.) 
column equipped with an RP-Select B, LiCroCART4-4 
pre-column. The mobile phase consisted of methanol and 
phosphate buffer solution (0.05 mol L-1, pH 4.5) (60:40, v/v). 
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Figure 1. Structure and pKa of selected SSRI antidepressants.
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Elution was carried out in the isocratic mode at room 
temperature (25 °C) and flow rate of 1.0 mL min−1. The 
mobile phase was filtered and degassed prior to use.
Electropolymerization process
For the development of SPME polythiophene phase, the 
cyclic voltammetry experiments were performed using a 
three-electrode system (Potentiostat/Galvanostat model PG 
Omnimetra 3901, coupled to a microcomputer operating 
with the software PG 3901). A platinum wire was utilized 
as the counter electrode, a silver/silver chloride (Ag/AgCl) 
electrode was used as reference and a cylindrical stainless 
steel 316 [1 cm × 2.32 mm i.d., composed of iron, nickel 
(7 to 20%) and chromium (17 to 25%)] was employed 
as the working electrode. Initially, the stainless steel was 
polished with steel wool and washed with ultra-pure water 
in an ultrasonic bath for 30 min. These electrodes were 
kept in acetone.
For the electrodeposition of thiophene, 0.1 mol L-1 
NaClO4 (electrolyte) in an acetonitrile solution containing 
0.3 mol L-1 of the monomer was evaluated at a scan rate 
of 50 mV s-1, within the −0.2 to 1.7 V potential range. 
Furthermore, TBATFB (0.5 mol L-1) in acetonitrile solution 
containing 0.3 mol L-1 of the monomer was also evaluated 
at a scan rate of 100 mV s-1, within the −0.2 and 2.2 V 
potential range.
The influence of the film thickness on the SPME 
performance was evaluated with 20 and 50 scan cycles 
for polythiophene electropolymerization in NaClO4 
(0.1 mol L-1) solution, and with 10, 15, 20 and 30 cycles 
in TBATFB (0.5 mol L-1) solution.
Scanning electron microscopy (SEM) of PTh coated SS 
surfaces
The surface of the polythiophene film coated on SS 
wire was cut into a 1 cm-long piece and then analyzed 
on a Zeiss EVO50 scanning electron microscope (20 kV 
accelerating potential).
Optimization of the SPME process
The SPME (electropolymerized polythiophene phase) 
variables such as time, temperature, matrix pH, sample 
volume and ionic strength were optimized in human plasma 
samples and investigated in triplicate assays. The stirring 
speed and polythiophene film dimension were kept constant 
during the optimization.
The influence of the matrix pH on the SPME 
performance was evaluated by the following procedure: in 
a glass vial (5 mL) sealed with a silicone septum, 3.0 mL 
buffer solution [0.05 mol L-1, phosphate buffer (pH 4.0 and 
7.0) and borate buffer (pH 9.0)] were added to 250 µL of 
a sample spiked with the drug standard solutions, which 
resulted in a drug concentration of 500 ng mL-1. The 
polythiophene electropolymerized electrode was immersed 
into the sample and the extractions were performed under 
magnetic stirring at a rate of 1200 rpm for 40 min at 25 °C. 
Then, the polythiophene electrode was inserted into a 
conical vial containing the mobile phase (static mode, 
250 µL) for 15 min at 25 °C. 20 µL of this extract were 
injected into the LC-UV system.
The volume of the plasma sample (250, 500 and 
1000 µL), extraction time (10, 20, 30 and 40 min) and 
temperature (25, 40 and 50 °C) were optimized to 
establish the sorption equilibrium between the drugs and 
the extraction phase. The influence of ionic strength on 
the SPME performance was also examined by addition of 
NaCl (0, 5 and 10% m/v).
For the desorption process, different solvents were 
evaluated (water, methanol and mobile phase). After 
the desorption process, the electrode was washed with 
methanol/water (1:1, v/v) solution for 20 min to ensure total 
removal of the analytes and plasma endogenous compounds.
Results and Discussion
Electropolymerization process
Cyclic voltammetry is a convenient tool for the coating 
of metallic electrodes. The one-step production of films, 
the fiber-to-fiber reproducibility and the control of fiber 
thickness by changing the number of scan cycles must be 
highlighted among its advantages.19-21
Some organic solvents and supporting electrolytes have 
been used in the electropolymerization of polythiophene 
film and its derivatives.15,16,20 The electrochemical properties 
of polythiophene films largely depend on the supporting 
electrolyte, especially on the type of anion.22-25 According 
to Wu and Pawliszyn,26 the use of different electrolytes 
enables manipulation of the functionality of the resulting 
polymers. Therefore, two electrolyte solutions (namely 
TBATFB and NaClO4) in acetonitrile were evaluated for 
the electrodeposition of polythiophene in order to increase 
the selectivity and efficiency of the extraction phase.12,27
The polythiophene phase electropolymerized in 
TBATFB/acetonitrile 0.5 mol L-1 electrolyte solution 
gave the best results. Different numbers of scan cycles 
(10, 15, 20 and 30) were evaluated in order to improve 
the SPME-polythiophene extraction performance. The 
polythiophene phase electropolymerized in TBATFB 
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by mean of 20 scan cycles resulted in homogenous and 
more stable films, as well as higher SPME efficiency. The 
polythiophene phase electropolymerized using over 20 scan 
cycles resulted in a morphologically unstable film regarding 
the SPME process.
The obtained cyclic voltammogram using the prepared 
electrode under the optimal electrodeposition conditions is 
shown in Figure 2.
The shape and the peak positions observed in the cyclic 
voltammograms can reflect the properties of the polymer.28 
The increasing current on successive cycles shows that the 
thickness polymer is increasing. The regular increase of the 
current on successive cycles also illustrates that the polymer 
is regularly increasing into a packed structure (Figure 2).
The morphology of the polythiophene phase (optimized 
electropolymerization conditions) was investigated by 
scanning electron micrography (SEM) (Figure 3). According 
to the SEM images, these films presented porous structure, 
which resulted in larger surface areas and favored the 
extractive capacity of the polymeric phase (Figure 3a and b). 
The thickness of the polythiophene coating (ca. 180.6 µm) 
was also estimated by SEM (Figure 3c).
According to the SS wire geometry (surface area 
0.771 cm2) and the polythiophene coating average thickness 
(180.6 µm), the developed polythiophene film presented an 
approximate volume of 14 µL.
Optimization of SPME variables
Drug ionization is related to the pH of the matrix 
(biological fluid), so the this variable could affect SPME 
performance. Thus, the pH adjustment could improve 
the sensitivity of the method.29 As shown in Figure 4a, 
the dilution of the plasma sample with phosphate buffer 
0.05 mol L-1 pH 9.0 increased the efficiency of the SPME 
procedure. In this condition, the drugs were partially 
ionizable, according to the pKa of the antidepressants 
(9.47 to 10.32).10,30 Plasma dilution with buffer solution at 
pH values higher than 9.0 resulted in precipitation of the 
proteins, thus, pH values above pH 9.0 were not evaluated.
The increase in the extraction temperature from 25 to 
50 °C decreased the average peak area of the extracted 
drugs (Figure 4b). With a temperature increase, diffusion 
coefficients and Henry`s constants are increased and 
partition coefficients to the extraction phase are decreased.31 
Figure 2. Cyclic voltammogram for the electrodeposition of polythiophene 
(SS electrode) in TBATFB/acetonitrile solution (0.5 mol L-1) at a scan rate 
of 100 mV s-1, during 20 cycles.
Figure 3. Scanning electron micrographs of the polythiophene phase: 
(a) 65-fold view, (b) 1000-fold view and (c) 700-fold view.
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Thus, the subsequent extraction was carried out at room 
temperature (25 °C) to ensure stability and robustness of 
the polythiophene films. 
Representative extraction time profiles (10-40 min) 
at 25 °C are shown in Figure 4c. Although the sorption 
equilibrium had not been reached at 40 min, this time was 
selected for subsequent analysis to save time. However, the 
extraction time and mass transfer conditions were strictly 
controlled to ensure good precision.29
Olszowy et al.16 compared the extraction efficiency of 
SPME-PTh phases to adrenolytic drug analysis in aqueous 
and plasma medium. The equilibrium time for this analysis 
had not been found until 16 min for both samples (aqueous 
and plasma). So, the authors conducted extractions out 
of equilibrium time (10 min) to improve the total time 
analysis.16
In the selected condition (pH 9.0, 40 min and 25 ºC), 
the proposed SPME-polythiophene/LC method displayed 
precision and accuracy for analysis of antidepressants. In 
agreement with Figure 4c, the competitive process among 
drugs and polythiophene phase was not observed up to 
40 min.
The influence of the ionic strength on the extraction 
process was evaluated by adding NaCl to the plasma sample 
(0, 5 and 10%) (data not shown). The polythiophene phase 
exhibited reduced extraction efficiency in saline solution 
because of the competition among the salt cations and the 
analytes. Probably, this happened due to electrostatic or 
ion-pairing interactions. This likely reduced the ability 
of the drugs to move into the fiber coating.8 In low saline 
concentration, there was no change in the extraction 
performance. 
Among the evaluated solvents for the desorption 
process (water, methanol and mobile phase), the mobile 
phase (phosphate buffer 0.05 mol L-1, pH 4.5 and methanol 
40:60, v/v) gave the best SPME performance (data not 
shown). The polythiophene phase showed to be stable in 
mobile phase.
Since the SPME process based on equilibrium sorption 
is not exhaustive (i.e., only a fraction of the sample is 
extracted),31,32 the volume of the plasma sample was also 
optimized. Different sample volumes (250, 500 and 1000 µL) 
were subjected to SPME-PTh/LC-UV analysis (Figure 5). 
According to the obtained results, a plasma sample volume 
above 250 µL slightly increases the efficiency of the 
polythiophene fiber on SPME performance. However, a 
small plasma volume, which was diluted with buffer solution, 
decreased the matrix viscosity and increased the diffusion 
Figure 4. The effect of pH of plasma samples (a), temperature (b) and 
time (c) on SPME performance.
Figure 5. The effect of plasma sample volume on SPME performance: 
plasma sample spiked with antidepressants at a concentration of 1000 ng 
mL-1 and diluted in 3.0 mL phosphate buffer, pH 9.0, 0.05 mol L-1 under 
stirring (1200 rpm).
SPME using a Polythiophene Film and LC Spectrophotometric Detection for the Determination of Antidepressants J. Braz. Chem. Soc.62
coefficients. This could reduce the extraction time and 
increase the lifetime of the polythiophene phase.
The optimized results, among those evaluated for 
direct SPME-PTh, were obtained under the conditions: 
250 µL plasma sample diluted with 3.0 mL borate buffer 
solution (0.05 mol L-1, pH 9.0), followed by immersion of 
the polythiophene electropolymerized electrode into the 
sample. The extractions were performed under magnetic 
stirring at a rate of 1200 rpm for 40 min at 25 °C. For 
the desorption process, the polythiophene electrode was 
inserted into a conical vial containing the mobile phase 
(static mode, 250 µL) for 15 min at 25 °C.
Analytical validation of the SPME-PTh/LC method
The selectivity of the SPME/LC method can be 
demonstrated by the chromatograms of (i) blank plasma 
spiked with antidepressants at 500 ng mL-1 and (ii) 
blank plasma (Figure 6). These chromatograms do not 
present interfering peaks at the retention time of the 
antidepressants. The synthetic plasma consisted of a 
solution with ionic strength and viscosity similar to that 
of the human plasma, but without the presence of human 
plasma proteins.18
Antidepressants may be prescribed in combination with 
different psychotropic agents and other drugs. Consequently, 
an evaluation of the interference (co-elution) of potential 
co-administered drugs was required. Different drug standards 
were injected in the LC-UV system to evaluate the co-elution 
with the analytes in the applied chromatographic conditions 
(Table 1). On the basis of the retention times, other drugs do 
not co-elute with the analytes.
The linearity and limit of quantification (LOQ) of the 
proposed SPME-PTh/LC method for human and synthetic 
plasma samples are illustrated in Table 2. The evaluated 
intervals for both plasma samples were linear, with 
correlation coefficients greater than 0.998. The LOQ was 
determined as the lowest concentration of the calibration 
curve, with CV lower than 15%, and chromatographic 
signal ten times greater than the signal-to-noise ratio.
The angular coefficients of the calibration curve 
(method sensitivity) and LOQ values of the SPME-PTh/LC 
method obtained for the synthetic plasma are lower than 
those obtained for the human plasma, Table 2.
The sensitivity of the SPME-PTh/LC method in human 
plasma samples could be improved using a fluorescence 
detector, which presented LOQ values in the order of 
50 ng mL-1 (data not shown).
Table 3 lists the values of interassay precision and 
accuracy of the SPME-PTh/LC method for determination 
of antidepressants in synthetic and human plasma samples.
Although the sensitivity of the method were reduced 
due to adsorption of plasma endogenous compounds onto 
the SPME phase (matrix effect), the polythiophene phase 
presented selectivity for extraction of antidepressants from 
the plasma sample.
Figure 6. SPME/LC chromatograms of (i) blank plasma spiked with 
antidepressants at 500 ng mL-1 and (ii) blank plasma, for analysis of 
(a) human plasma and (b) synthetic plasma, containing (1) citalopram, 
(2) paroxetine, (3) fluoxetine and (4) sertraline.
Table 1. Retention time of the studied drugs as possible interferents
Drugs Retention time / min
Ascorbic acid 1.05
Primidone 1.95
Caffeine 2.58
Phenacetine 3.14
Diclofenac 3.67
Moclobemide 3.73
Diazepam 4.19
Propanolol 5.04
Citalopram 5.21
Clonazepam 5.85
Carbamazepine 5.97
Phenytoin 6.13
Mirtazapine 7.34
Paroxetine 9.72
Fluoxetine 13.06
Sertraline 16.30
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In addition, the relative recovery (Table 4) of drugs from 
human plasma compared with drug recovery from synthetic 
plasma was also calculated by using the mean slopes of 
the constructed curves for the human and synthetic plasma 
samples (equation 1). The relative recovery correlates the 
analytical sensitivity of the method in different matrices, 
human and synthetic plasma samples, thus illustrating the 
effect of the endogenous compounds on the SPME process.
 (1)
The recovery rates of the plasma samples of the SPME/LC 
method using polythiophene phase for determination of 
adrenolytic drugs (metoprolol, oxprenolol, mexiletine, 
propranolol and propaphenon) were lower than those 
obtained for aqueous samples. The authors did not 
obtain enough sensitivity for therapeutic drug monitoring 
analysis (LC-UV method), but according to them, some 
modifications could improve the method sensitivity.16
The fiber-to-fiber reproducibility, or rather, the 
reproducibility of the electrochemical coating procedure, 
was also investigated. The average results (n = 5) from the 
SPME-PTh/LC determination carried out with three different 
fibers were very similar, with coefficients of variation (CV) 
ranging from 7 to 13%. These assays were carried out with 
human plasma samples spiked with drugs (500 ng mL-1).
Conclusion
The developed PTH film electropolymerized in 
acetonitrile solution containing TBATFB is an inexpensive 
promising alternative for the development of new phases 
for the SPME technique.
Although the sensitivity of the method was reduced 
due to adsorption of plasma endogenous compounds onto 
the SPME phase (matrix effect), the polythiophene phase 
presented selectivity for extraction of antidepressants 
from the plasma sample. The competitive process (limited 
number of surface sites) among drugs and polythiophene 
phase was not observed.
The sensitivity of the SPME-PTh/LC method in human 
plasma samples could be improved using a fluorescence 
detector, which presented LOQ values in the order of 
50 ng mL-1.
The proposed method can be a useful tool for the 
determination of antidepressants in human plasma samples 
in urgent toxicological analysis after the accidental or 
suicidal intake of medication in higher doses.
Table 2. Linearity and limit of quantification (LOQ) of SPME-PTh/LC for simultaneous analysis of antidepressants in plasma samples
Drug Linear regressiona r2 LOQ / (ng mL-1)
Synthetic plasma 
a(LOQ: 1000 ng mL-1)
citalopram y = 3066.4 + 35.9 x 0.998 50
paroxetine y = 3539.3 + 125.0 x 0.999 25
fluoxetine y = 4235.2 + 113.4 x 0.999 25
sertraline y = 2454.18 + 8.94 x 0.998 25
Human plasma 
a(LOQ: 4000 ng mL-1)
citalopram y = 6059.5 + 2.49 x 0.998 250
paroxetine y = 17862.0 + 4.79 x 0.998 200
fluoxetine y = 16777.6 + 2.15 x 0.999 250
sertraline y = 28259.3 + 9.66 x 0.999 200
Table 3. Accuracy and inter-assay precision (coefficient of variation, 
CV) of the SPME-PTh/LC-UV method for analysis of plasma samples
Drugs
Added 
concentration / 
(ng mL-1)
Accuracy / % 
(n = 5)
CV / % 
(n = 5)
Synthetic 
plasma
citalopram 50 101 5.6
paroxetine 25 98 3.7
fluoxetine 25 112 3.9
sertraline 25 92 6.8
Human 
plasma
citalopram 250 82 13
paroxetine 200 76 15
fluoxetine 250 87 11
sertraline 200 79 14
Table 4. Ratio between the slopes of the SPME/LC calibration curves 
obtained for the human and synthetic plasma samples, and recovery, as 
estimated by equation 1
Drugs Ratio between 
the slopes
Relative 
recovery / %
Citalopram 0.25 25
Paroxetine 0.19 19
Fluoxetine 0.39 39
Sertraline 0.29 29
SPME using a Polythiophene Film and LC Spectrophotometric Detection for the Determination of Antidepressants J. Braz. Chem. Soc.64
Acknowledgments
This work was supported by grants from Fundação de 
Amparo à Pesquisa do Estado de São Paulo (FAPESP) 
and Conselho Nacional de Desenvolvimento Científico e 
Tecnológico (CNPq).
References
 1. Feldmann Jr., R. E.; Sawa, A.; Seidler, G. H.; J. Psychiatr. Res. 
2007, 41, 713.
 2. Nash, J.; Nutt, D.; Psychiatry 2007, 6, 289.
 3. Frey, R.; Schreinzer, D.; Stimpfl, T.; Vycudilik, W.; Berzlanovich, 
A.; Kasper, S.; Eur. Neuropsychopharmacol. 2000, 10, 133.
 4. Ohberg, A.; Vuori, E.; Klaukka, T.; Lonnqvist, J.; J. Affect. 
Disord. 1998, 50, 225.
 5. Jick, S. S.; Dean, A. D.; Jick, H.; Br. Med. J. 1995, 310, 215.
 6. Rubino, A.; Roskell, N.; Tennis, P.; Mines, D.; Weich, S.; 
Andrews, E.; Br. Med. J. 2007, 334, 242.
 7. Malmvik, J.; Liiwenhielm, C. G. P.; Melander, A.; Eur. J. Clin. 
Pharmacol. 1994, 46, 291.
 8. Kataoka, H.; Trends Analyt. Chem. 2003, 22, 232.
 9. Arthur, C. L.; Pawliszyn, J.; Anal. Chem. 1990, 62, 2145.
 10. Chaves, A. R.; Chiericato Jr., G.; Queiroz, M. E. C.; 
J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2009, 
877, 587.
 11. Wu, J.; Pawliszyn, J.; Anal. Chim. Acta 2004, 520, 257.
 12. Gbatu, T. P.; Ceylan, O.; Sutton, K. L.; Rubinson, J. F.; Galal, A.; 
Caruso, J. A.; Mark Jr., H. B.; Anal. Commun. 1999, 36, 203.
 13. Yates, B. J.; Temsamani, K. R.; Ceylan, O.; Oztemiz, S.; Gbatu, 
T. P.; La Rue, R. A.; Tamer, U.; Mark Jr., H. B.; Talanta 2000, 
58, 739.
 14. Tamer, U.; Yates, B.; Galal, A.; Gbatu, T.; LaRue, R.; 
Schmiesing, C.; Temsamani, K.; Ceylan, O.; Mark Jr., H.; 
Microchim. Acta 2003, 143, 205.
 15. Olszowy, P.; Szultka, M.; Fuchs, P.; Kegler, R.; Mundkowski, R.; 
Miekisch, W.; Schubert, J.; Buszewski, B.; J. Pharm. Biomed. 
Anal. 2010, 53, 1022.
 16. Olszowy, P.; Szultka, M.; Ligor, T.; Nowaczyk, J.; Buszewski, B.; 
J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2010, 
878, 2226.
 17. Mehdinia, A.; Ghassempour, A.; Rafati, H.; Heydari, R.; Anal. 
Chim. Acta 2007, 587, 82.
 18. Holme, S.; Heaton, W. A.; Transfus. Sci. 1994, 15, iv.
 19. Bagheri, H.; Babanezhad, E.; Es-haghi, A.; J. Chromatogr., A 
2007, 1152, 168.
 20. Li, X.; Li, C.; Chen, J.; Li, C.; Sun, C.; J. Chromatogr., A 2008, 
1198-1199, 7.
 21. Huang, M.; Jiang, G.; Cai, Y.; J. Sep. Sci. 2005, 28, 2218.
 22. Kabasakaloglu, M.; Kiyak, T.; Toprak, H.; Aksu, M. L.; Appl. 
Surf. Sci. 1999, 152, 115.
 23. Shen, L.; Xu, J.; Wei, Z.; Xiao, Q.; Pu, S.; Eur. Polym. J. 2005, 
41, 1738.
 24. Abou-Elenien, G. M.; El-Maghraby, A. A.; El-Abdallah, G. M.; 
Synth. Met. 2004, 146, 109.
 25. Vignali, M.; Edwards, R. A. H.; Serantoni, M.; Cunnane, V. J.; 
J. Electroanal. Chem. 2006, 591, 59.
 26. Wu, J.; Pawliszyn, J.; J. Chromatogr., A 2001, 909, 37.
 27. Sarac, A. S.; Geyik, H.; Parlak, E. A.; Serantoni, M.; Prog. Org. 
Coat. 2007, 59, 28.
 28. Zhou, M.; Heinze, J.; Electrochim. Acta 1999, 44, 1733.
 29. Mester, Z.; Sturgeon, R.; Spectrochim. Acta, Part B 2005, 60, 
1243.
 30. Vasskog, T.; Berger, U.; Samuelsen, P. J.; Kallenborn, R.; Jensen 
E.; J. Chromatogr., A 2006, 1115, 187.
 31. Lord, H.; Pawliszyn, J.; J. Chromatogr., A 2000, 902, 17.
 32. Theodoridis, G.; Koster, E. H. M.; de Jong, G. J.; J. Chromatogr., 
B: Anal. Technol. Biomed. Life Sci. 2000, 745, 49.
Submitted: December 20, 2010
Published online: October 18, 2011
FAPESP has sponsored the publication of this article.
